• search

HRL set to cater pharma, biotech companies

Written by: Staff

Chennai, Oct 24: The city-based Huclin Research Limited (HRL), an independent clinical research organization (CRO), today announced commencement of a full array of clinical research activities to cater to pharmaceutical and biotechnology companies.

Strategically located in TICEL Bio-Park, HRL would provide high standard quality clinical research services like design and conduct of Bioavailability, Bioequivalence studies, including fasting study, food effect study, Pharmacokinetic and Pharmacodynamic (PK-PD) studies, individual bioequivalence and special population studies.

HRL has installed sophisticated, advanced and automated equipments for the bio-analytical lab.

HRL Executive Director Mahalingam Vasudevan said the company had invested Rs seven crore for setting up a bio-analytical facility and clinical beds at Ticel Bio-Park.

In the second phase, an additional Rs 15 crore will be spent on developing multi-centric trial centers across India, a HRL release said.

The company has also created quality infrastructure to conduct clinical trial services including the design and conduct of phase I to IV studies, protocol design and development, optimizing clinical trial design and patient population, designing of case record form (CRF and design and development of Patient Information Leaflets (PIL) and Quality of Life (QoL) forms.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more